My Blog List

Tuesday, 21 November 2017

Lung Cancer Diagnostic Tests Market Estimated to Grow Strongly by 2022

Description:

In this report, the Asia-Pacific Lung Cancer Diagnostic Tests market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Lung Cancer Diagnostic Tests for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia


Asia-Pacific Lung Cancer Diagnostic Tests market competition by top manufacturers/players, with Lung Cancer Diagnostic Tests sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US


On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Precision Medicine
Personalized Medicine
Cancer Monitoring

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1156878&req_type=disc

Table of Content:

1 Lung Cancer Diagnostic Tests Overview1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
1.2 Classification of Lung Cancer Diagnostic Tests by Product Category
1.2.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (Sales) Comparison by Types (2012–2022)
1.2.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Immunoassays
1.2.4 Flow Cytometry
1.2.5 Rapid Tests
1.2.6 Molecular Assays
1.2.7 Tissue Arrays
1.2.8 Circulating Tumor Cells
1.2.9 Pharmacodiagnostics
1.2.10 Biomarkers
1.2.11 Other Diagnostics Methods
1.3 Asia-Pacific Lung Cancer Diagnostic Tests Market by Application/End Users
1.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales (Volume) and Market Share Comparison by Applications (2012–2022)
1.3.2 Precision Medicine
1.3.3 Personalized Medicine
1.3.4 Cancer Monitoring
1.4 Asia-Pacific Lung Cancer Diagnostic Tests Market by Region
1.4.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (Value) Comparison by Region (2012–2022)
1.4.2 China Status and Prospect (2012–2022)
1.4.3 Japan Status and Prospect (2012–2022)
1.4.4 South Korea Status and Prospect (2012–2022)
1.4.5 Taiwan Status and Prospect (2012–2022)
1.4.6 India Status and Prospect (2012–2022)
1.4.7 Southeast Asia Status and Prospect (2012–2022)
1.4.8 Australia Status and Prospect (2012–2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Lung Cancer Diagnostic Tests (2012–2022)
1.5.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales and Growth Rate (2012–2022)
1.5.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012–2022)

2 Asia-Pacific Lung Cancer Diagnostic Tests Competition by Players/Suppliers, Region, Type and Application2.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume and Market Share of Key Players/Suppliers (2012–2017)
2.1.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Share by Players/Suppliers (2012–2017)
2.2 Asia-Pacific Lung Cancer Diagnostic Tests (Volume and Value) by Type
2.2.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales and Market Share by Type (2012–2017)
2.2.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2012–2017)
2.3 Asia-Pacific Lung Cancer Diagnostic Tests (Volume) by Application
2.4 Asia-Pacific Lung Cancer Diagnostic Tests (Volume and Value) by Region
2.4.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales and Market Share by Region (2012–2017)
2.4.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Market Share by Region (2012–2017)
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India